Symptoms of Raynaud's phenomenon in an inner-city African-American community: Prevalence and self-reported cardiovascular comorbidity

Journal of Clinical Epidemiology

Volumn 52, Issue 5, 1999, Pages 441-446

  Gelber, Allan C ^a   Wigley, Fredrick M ^a   Stallings, Rebecca Y ^a   Bone, Lee R ^a   Barker, Anne V ^a   Baylor, Ingrid ^a   Harris, Clyde W ^a   Hill, Martha N ^a   Zeger, Scott L ^a   Levine, David M ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

African American community; Prevalence; Raynaud's phenomenon

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; UNITED STATES;

ADULT; AFRICAN AMERICANS; BALTIMORE; CARDIOVASCULAR DISEASES; COLD; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PREVALENCE; RAYNAUD DISEASE; URBAN HEALTH;

EID: 0032975472     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(99)00015-3     Document Type: Article

References (33)

1. Raynaud M. On Local Asphyxia and Symmetrical Gangrene of the Extremities. 1888;The New Sydenham Society, London.
2. Allen E.V., Brown G.E. Raynaud's disease. A critical review of minimal requisites for diagnosis Am J Med Sci. 183:1932;187-200.
3. Kallenberg C.G.M., Wouda A.A., Hoet M.H., Venrooij W.J.V. Development of connective tissue disease in patients presenting with Raynaud's phenomenon. A six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting Ann Rheum Dis. 47:1988;634-641.
4. Silman A., Holligan S., Brennan P., Maddison P. Prevalence of symptoms of Raynaud's phenomenon in general practice. BMJ. 301:1990;590-592.
5. Heslop J., Coggon D., Acheson E.D. The prevalence of intermittent digital ischaemia (Raynaud's phenomenon) in a general practice. J R Coll Gen Pract. 33:1983;85-89.
6. Maricq H.R., Carpentier P.H., Weinrich M.C., Keil J.E., Franco A., Drouet P.et al. Geographic variation in the prevalence of Raynaud's phenomenon. Charleston, SC, USA vs Tarentaise, Savoie, France J Rheumatol. 20:1993;70-76.
7. Maricq H.R., Carpentier P.H., Weinrich M.C., Keil J.E., Palesch Y., Biro C.et al. Geographic variation in the prevalence of Raynaud's phenomenon. A 5 region comparison J Rheumatol. 24:1997;879-889.
8. Bartelink M.L., Wollersheim H., van de Lisdonk E., Spruijt R., van Weel C. Prevalence of Raynaud's phenomenon. Neth J Med. 41:1992;149-152.
9. Leppert J., Aberg H., Ringqvist I., Sorensson S. Raynaud's phenomenon in a female population. Prevalence and association with other conditions Angiology. 38:1987;871-877.
10. Riera G., Vilardell M., Vaque J., Fonollosa V., Bermejo B. Prevalence of Raynaud's Phenomenon in a healthy Spanish population. J Rheumatol. 20:1993;66-69.
11. Valter I., Maricq H.R. Prevalence of Raynaud phenomenon in Tartu and Tartumaa, Southern Eastonia. Scand J Rheumatol. 26:1997;117-124.
12. Harada N., Ueda A., Takegata S. Prevalence of Raynaud's phenomenon in Japanese males and females. J Clin Epidemiol. 44:1991;649-655.
13. Maricq H.R., Weinrich M.C., Keil J.E., LeRoy E.C. Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire J Chron Dis. 39:1986;423-427.
14. Weinrich M.C., Maricq H.R., Keil J.E., McGregor A.R., Diat F. Prevalence of Raynaud phenomenon in the adult population of South Carolina. J Clin Epidemiol. 43:1990;1343-1349.
15. Fessel W.J. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med. 134:1974;1027-1035.
16. Siegel M., Lee S.L. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum. 3:1973;1-54.
17. Laing T.J., Gillespie B.W., Toth M.B., Mayes M.B., Gallavan R.H., Burns C.J.et al. Racial differences in scleroderma among women in Michigan. Arthritis Rheum. 40:1997;734-742.
18. Mason J.O. Understanding the disparities in morbidity and mortality among racial and ethnic groups in the United States. Ann Epidemiol. 3:1993;120-124.
19. Levine D.M., Becker D.M., Bone L.R., Hill M.N., Tuggle M.B., Zeger S.L. Community-academic health center partnerships for underserved minority populations. One solution to a national crisis JAMA. 272:1994;309-311.
20. Levine D.M., Becker D.M., Bone L.R. Narrowing the gap in health status of minority populations. A community-academic medical center partnership Am J Prev Med. 8:1992;319-323.
21. Hill M.N., Bone L.R., Butz A.M. Enhancing the role of community-health workers in research. Image: J Nursing Scholarship. 28:1996;221-226.
22. Richter R.W., Bengen B., Alsup P.A., Bruun B., Kilcoyne M.M., Challenor B.D. The community health worker. A resource for improved health care delivery Am J Pub Health. 64:1974;1056-1061.
23. Collins JG. Prevalence of selected chronic conditions: United States, 1990-1992. Vital Health Stat 10 1997: 194.
24. Cohen RA, Bloom B, Simpson G, Parsons PE. Access to health care. Part 3: Older adults. 1997. Vital Health Stat 10 1997: 198.
25. Jack SS. Current estimates from the national health interview survey: Unites States, 1979. Vital Health Stat 10 1979: 136.
26. Heagerty P.J., Zeger S.L. Marginal regression models for clustered ordinal measurements. J Am Stat Assoc. 91:1996;1024-1036.
27. Marshall A.J., Roberts C.J.C., Barritt D.W. Raynaud's phenomenon as side effect of beta-blockers in hypertension. BMJ. 1:1976;1498-1499.
28. Franssen C., Wollersheim H., de Haan A., Thien T. The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension. J Clin Pharm. 32:1992;652-659.
29. Medsger T.A., Masi A.T. Epidemiology of systemic sclerosis (scleroderma). Ann Intern Med. 74:1971;714-721.
30. Freedman B.I., Wilson C.H., Spray B.J., Tuttle A.B., Olorenshaw I.M., Kammer G.M. Familial clustering of end-stage renal disease in blacks with lupus nephritis. Am J Kidney Dis. 29:1997;729-732.
31. Brennan P., Silman A., Black C., Bernstein R., Coppock J., Maddison P.et al. Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. Br J Rheumatol. 32:1993;357-361.
32. Maricq H.R., McGregor A.R., Diat F., Smith E.A., Maxwell D.B., LeRoy E.C.et al. Major clinical diagnoses found among patients with Raynaud Phenomenon from the general population. J Rheumatol. 17:1990;1171-1176.
33. Prewitt E., American College of Physicians Inner-city health care. Ann Intern Med. 127:1997;485-490.